Mental Health

Comprehensive Mental Health Adherence Testing That Identifies What Is Not Seen Today

The challenges to mental health care posed by the pandemic are vast. In addition to significantly increased reports of anxiety and depression, and a sharp decrease in needed medical care, clinicians are seeing worsening mental health outcomes, increased substance use, and elevated suicidal ideation.¹

According to a recent survey, 41% of adults reported symptoms of anxiety and/or depressive disorder in January 2021 (a significant increase from the 11% reported during the same period in 2019) and 36% reported delaying or not getting the medical care they need because of the pandemic.² Additionally, 13% of adults reported new or increased substance use due to coronavirus-related stress, and 11% reported thoughts of suicide in the past 30 days.¹

¹https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a1.htm
²https://www.cdc.gov/nchs/covid19/pulse/mental-health.htm

It is more important than ever that clinicians have insight into potentially high-risk patient behavior and non-adherence to their treatment plan.

Extensive Mental Health Test Menu

Navis Clinical offers an extensive drug testing menu with over 180 metabolites and parent drugs, with more than 60 mental health testing options.

INTEGRATED RESULTS MANAGEMENT REPORTS

Laboratory results management reports allow you to easily monitor your testing protocols, testing frequency and positivity trends to help you offer better care for your patients.

What are you missing?

An analysis of drug test results from mental health patients where medications were reported as prescribed revealed surprising insights:

65%

Demonstrated inconsistent results

38%

Tested negative for prescribed medications

19%

Tested positive for illicit drugs

32%

Tested positive for non-prescribed medications

Analysis of 17,720 samples from mental health patients where a medication was reported as prescribed with the test order; Jan 2018–Sept 2019

Medication non-adherence accounts for 30–50% of treatment failures.

Studies show that patients often overstate adherence because they fear disappointing their provider and that clinicians generally overestimate their own ability to identify and quantify non-adherence among their patients, highlighting the importance of objective and validated approaches to measurement, such as testing.

Non-adherence to antipsychotic medications averages 42%
Non-adherence to antidepressant medications averages 34%

Medication Matters: Causes and Solutions to Medication Non-Adherence National Council for Behavioral Health’s Medical Director Institute, September 2018

Non-adherence to medication represents a major problem that limits the effectiveness of treatment and adds to the burden of illness and cost of health care.

Drug testing is an effective technology when the right test is selected for the right person at the right time.

Medication adherence should be periodically monitored by laboratory testing.

Results should be used to guide patient care, modify treatment plans and confirm clinical impressions.

Based on risk assessment, match provider interventions with medication regimens to patient’s individual needs.